While stem cells from bone marrow have become an established therapy for a handful of blood cancers - and while there are high hopes that the cells will someday lead to other major medical advances - critics say entrepreneurs are treating patients with little or no evidence that what they do is effective. George Daley, professor of biological chemistry and molecular pharmacology at Boston Children’s Hospital, is quoted.
Trending News
Research Provides Clues to Spleen’s Role in Coronary Artery Disease
Genetic variants may drive visible changes in the spleen that contribute to heart disease
Patient Who Received Pig Kidney Becomes First To Progress to Human Kidney Transplant
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease
Pilots, Flight Attendants Have Greater Risk of Radiation-Related Cancer Death Than Other Professions
Findings support efforts to protect U.S. aircrews from cosmic radiation exposure